PB
PBH.US Prestige Brand Holdings Inc
- Market cap
- USD 2.28B
- P/E
- 14.8x
- P/B
- 1.13x
- ROE
- 5.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.
Is PBH.US undervalued?
Graham numberPBH.US trades 13.9% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Prestige Brand Holdings Inc fundamental analysis
No fundamental analysis for Prestige Brand Holdings Inc yet.
Prestige Brand Holdings Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Prestige Brand Holdings Inc
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Bu…
Full company profilePrestige Brand Holdings Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Prestige Brand Holdings Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 882M | 1.04B | 976M | 963M | 943M | 1.09B | 1.13B | 1.13B | 1.14B | 1.09B | 1.20B |
| Gross Profit | 500M | 577M | 556M | 552M | 547M | 621M | 625M | 624M | 634M | 575M | 617M |
| Operating Income | 206M | 216M | 67.5M | 291M | 297M | 330M | -22.4M | 342M | 337M | 309M | 266M |
| EBITDA | 304M | 356M | 98.8M | 317M | 317M | 359M | 7.87M | 374M | 362M | 331M | 301M |
| Net Income | 69.4M | 340M | -35.8M | 142M | 165M | 205M | -82.3M | 209M | 215M | 190M | 109M |
| EPS | 1.30 | 6.34 | -0.69 | 2.78 | 3.25 | 4.04 | -1.65 | 4.17 | 4.29 | 3.91 | 2.29 |
| Balance Sheet | |||||||||||
| Total Assets | 3.91B | 3.76B | 3.44B | 3.51B | 3.43B | 3.67B | 3.35B | 3.32B | 3.40B | 3.55B | 4.72B |
| Total Liabilities | 3.09B | 2.58B | 2.35B | 2.34B | 2.07B | 2.09B | 1.91B | 1.66B | 1.57B | 1.66B | 2.78B |
| Shareholders' Equity | 823M | 1.18B | 1.10B | 1.17B | 1.36B | 1.58B | 1.45B | 1.66B | 1.83B | 1.89B | 1.94B |
| Cash & Short-term Investments | 41.9M | 32.5M | 27.5M | 94.8M | 32.3M | 27.2M | 58.5M | 46.5M | 97.9M | 63.9M | 46.5M |
| Total Debt | 2.19B | 1.99B | 1.80B | 1.77B | 1.51B | 1.51B | 1.37B | 1.14B | 1.04B | 1.05B | 2.12B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 148M | 210M | 189M | 217M | 236M | 260M | 230M | 249M | 252M | 258M | 217M |
| Capital Expenditure | 2.98M | 12.5M | 10.5M | 14.6M | 22.2M | 9.64M | 7.78M | 9.55M | 8.22M | 11.2M | 14.7M |
| Free Cash Flow | 145M | 198M | 179M | 203M | 213M | 250M | 222M | 239M | 243M | 246M | 203M |
| Ratios | |||||||||||
| ROE | 8.4% | 28.8% | -3.3% | 12.2% | 12.1% | 13.0% | -5.7% | 12.6% | 11.7% | 10.1% | 5.6% |
| ROA | 1.8% | 9.0% | -1.0% | 4.0% | 4.8% | 5.6% | -2.5% | 6.3% | 6.3% | 5.4% | 2.3% |
| Net Profit Margin | 7.9% | 32.6% | -3.7% | 14.8% | 17.5% | 18.9% | -7.3% | 18.6% | 18.9% | 17.5% | 9.0% |
| Debt to Equity | 2.67x | 1.69x | 1.64x | 1.51x | 1.12x | 0.95x | 0.94x | 0.69x | 0.57x | 0.55x | 1.09x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Prestige Brand Holdings Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Dec 27, 2013
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | USD 4.12M | 0.08 | 2.0% |
| 2021 | USD 2.85M | 0.06 | 1.7% |
| 2020 | USD 1.32M | 0.03 | 0.9% |
| 2019 | USD 2.93M | 0.06 | - |
| 2018 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Prestige Brand Holdings Inc
- Insiders 2.63%
- Institutions 97.37%
- Public & others 0.00%
- Shares outstanding 47.4M
- Free float 46.7M
Top funds holding PBH.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 2.85M | 6.01% | -0.13% | Oct 2026 |
| Undiscovered Managers Behavioral Val L | 2.06M | 4.34% | +13.51% | Sep 2026 |
| Ariel Fund Investor | 1.79M | 3.79% | +5.32% | Sep 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.52M | 3.21% | +0.53% | Sep 2026 |
| iShares Russell 2000 ETF | 1.21M | 2.56% | 0.00% | Oct 2026 |
| Vanguard Small Cap Index | 1.07M | 2.25% | -1.98% | Sep 2026 |
| DFA U.S. Small Cap Value I | 830K | 1.75% | +30.71% | Sep 2026 |
| Vanguard MStar Small Cap Value Index | 694K | 1.46% | +0.28% | Sep 2026 |
| Bridge Builder Small Cap Fund | 624K | 1.32% | -2.53% | Oct 2026 |
| Allspring Special Small Cap Value A | 588K | 1.24% | -9.93% | Sep 2026 |
| Fidelity Small Cap Index | 525K | 1.11% | +0.18% | Aug 2026 |
| JHancock Small Cap Core NAV | 518K | 1.09% | 0.00% | Sep 2026 |
| Brandes Small Cap Value R6 | 517K | 1.09% | +9.75% | Sep 2026 |
| iShares Russell 2000 Value ETF | 452K | 0.95% | 0.00% | Oct 2026 |
| State Street SPDR Port S&P 600 Sm CpETF | 433K | 0.91% | -0.05% | Oct 2026 |
| Ariel Appreciation Investor | 406K | 0.86% | 0.00% | Sep 2026 |
| iShares S&P Small-Cap 600 Value ETF | 392K | 0.83% | 0.00% | Oct 2026 |
| MFS New Discovery Value I | 383K | 0.81% | -4.64% | Sep 2026 |
| Virtus KAR Small-Cap Value I | 369K | 0.78% | 0.00% | Jun 2026 |
| Brandes Global Small Cap Equity Cl F | 358K | 0.76% | -10.09% | Oct 2026 |
Top institutions holding PBH.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 7.83M | 16.52% | +5.99% | Jun 2026 |
| Ariel Investments, LLC | 4.87M | 10.27% | +13.91% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 2.83M | 5.96% | +0.77% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 2.65M | 5.59% | -0.44% | Sep 2026 |
| Fuller & Thaler Asset Management Inc | 2.33M | 4.92% | 0.00% | Jun 2026 |
| Vanguard Capital Management, LLC | 2.14M | 4.51% | +2.10% | Jun 2026 |
| State Street Corp | 2.12M | 4.47% | +7.38% | Jun 2026 |
| Brandes Investment Partners & Co | 2.05M | 4.33% | +140.14% | Jun 2026 |
| Kayne Anderson Rudnick Investment Management LLC | 1.87M | 3.95% | -15.01% | Jun 2026 |
| Geode Capital Management, LLC | 1.57M | 3.32% | +7.65% | Jun 2026 |
| Allspring Global Investments Holdings, LLC | 1.27M | 2.68% | -18.37% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 1.24M | 2.62% | -8.36% | Jun 2026 |
| Nordea Investment Mgmt Bank Demark A/s | 824K | 1.74% | -0.57% | Sep 2026 |
| Northern Trust Corp | 773K | 1.63% | +3.08% | Jun 2026 |
| Westwood Holdings Group Inc | 750K | 1.58% | -32.98% | Jun 2026 |
| Rice Hall James & Associates, LLC | 690K | 1.46% | +32.22% | Jun 2026 |
| Manufacturers Life Insurance Co | 659K | 1.39% | +39.21% | Jun 2026 |
| Charles Schwab Investment Management Inc | 654K | 1.38% | -11.85% | Jun 2026 |
| UBS Group AG | 639K | 1.35% | +62.82% | Jun 2026 |
| Massachusetts Financial Services Company | 630K | 1.33% | +5.32% | Jun 2026 |
Prestige Brand Holdings Inc company profile
- Company name
- Prestige Brand Holdings Inc
- Ticker
- PBH.US
- Exchange
- USA Stocks
- Listed since
- Feb 10, 2005
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 890
- Fiscal year end
- March
- Address
- 660 White Plains Road, Tarrytown, NY, United States, 10591
- Phone
- 914 524 6800
- Website
- prestigebrands.com
About Prestige Brand Holdings Inc
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Prestige Brand Holdings Inc management
7- Mr. Ronald M. Lombardi CPAChairman, President & CEO · born 1964
- Ms. Christine Sacco CPACFO & COO · born 1976
- Mr. William C. P'Pool J.D.Senior VP, General Counsel & Corporate Secretary · born 1965
- Mr. Adel MekhailExecutive Vice President of Marketing & Sales · born 1961
- Mr. Philip David Terpolilli C.F.A.Director of Investor Relations
- Dean SiegalDirector of Communications
- Mr. Jose Luis RosadoSenior Vice President of Quality & Regulatory Affairs